These results indicated that inflammatory response signaling has a positive effect on prognosis, while the mitotic cell cycle and IL6/JAK/STAT3 signaling are prominent risk factors for ccRCC patients. The gene discussed is STAT3; the disease is nonpapillary renal cell carcinoma.